中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

2020 Vol. 36, No. 5

Display Method:
Editorial
Advances and challenges in immune control and functional cure of chronic hepatitis B
Zheng Xin, Liu Jia, Wu Jun, Meng ZhongJi, Lu MengJi, Yang DongLiang
2020, 36(5): 961-964. DOI: 10.3969/j.issn.1001-5256.2020.05.001
Abstract(1543) PDF (2135KB)(405) Cited By (13)
Abstract:

The clinical outcome of hepatitis B virus(HBV) infection mostly depends on the interaction between HBV and host immune system. Although there are still no drugs for the radical treatment of hepatitis B at present, more and more studies have found that functional cure, characterized by persistent neg...

Discussions by experts
Role and mechanism of action of intrahepatic intrinsic antigen-presenting cells in regulating anti-hepatitis B virus immune response
Xie XiaoHong, Yang DongLiang, Liu Jia
2020, 36(5): 965-970. DOI: 10.3969/j.issn.1001-5256.2020.05.002
Abstract(1230) PDF (1928KB)(239) Cited By (4)
Abstract:

The liver has a unique immune microenvironment, and the intrinsic antigen-presenting cells in the liver interact with each other and form a network to accurately regulate the homeostasis between liver immune tolerance and immune response. During hepatitis B virus(HBV) infection, on the one hand, the...

Hepatitis B cured by the activation of intrahepatic innate immunity:Research advances and new strategies
Huang KuiYuan, Liu ZiYing, Zhang XiaoYong
2020, 36(5): 971-976. DOI: 10.3969/j.issn.1001-5256.2020.05.003
Abstract(1203) PDF (2203KB)(272) Cited By (2)
Abstract:

Host innate and adaptive immune responses are essential for the clearance of hepatitis B virus(HBV). Patients with chronic HBV infection have defects in innate and specific immune responses against HBV, which cannot effectively eliminate the virus and may result in persistent virus replication and l...

Functional cure of chronic hepatitis B from the perspective of specific immune cells for hepatitis B virus
Liu XiaoJu, Zhang Zheng
2020, 36(5): 977-979. DOI: 10.3969/j.issn.1001-5256.2020.05.004
Abstract(1484) PDF (1882KB)(310) Cited By (5)
Abstract:

Functional cure of chronic hepatitis B(CHB) marks sustained virological inhibition and immunological control and is the ideal treatment goal recommended by the latest guidelines for the prevention and treatment of CHB in China and foreign countries. CHB patients can achieve virological inhibition wi...

Functional status of hepatitis B virus-specific T cells in patients with chronic hepatitis B virus infection:Exhausted or silenced?
Wang HaoLiang, Deng GuoHong
2020, 36(5): 980-982. DOI: 10.3969/j.issn.1001-5256.2020.05.005
Abstract(1216) PDF (1891KB)(243) Cited By (5)
Abstract:

Hepatitis B virus(HBV)-specific T cells in patients with chronic HBV infection are currently acknowledged as exhausted T cells. This article summarizes previous studies which support this hypothesis and then points out several inconsistencies between this hypothesis and clinical observation. Based o...

Regulatory mechanisms of the transcription and metabolism of hepatitis B virus covalently closed circular DNA and strategies for silencing and elimination
Zai WenJing, Chen JieLiang, Yuan ZhengHong
2020, 36(5): 983-988. DOI: 10.3969/j.issn.1001-5256.2020.05.006
Abstract(1606) PDF (1929KB)(358) Cited By (6)
Abstract:

It is known that hepatitis B virus(HBV) covalently closed circular DNA(cccDNA) persists in the nucleus of infected hepatocytes in the form of minichromosome and is difficult to target and eliminate. Studies on the mechanisms and strategies for persistent silencing or elimination of HBV cccDNA are th...

Guidelines
An excerpt of care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID expert consensus(2020)
Zheng KeXin, Yang Ling, Qi XingShun
2020, 36(5): 989-990. DOI: 10.3969/j.issn.1001-5256.2020.05.007
Abstract:
An excerpt of SCCM Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU (2020)
Li Hui, Su HaiBin
2020, 36(5): 991-995. DOI: 10.3969/j.issn.1001-5256.2020.05.008
Abstract(1468) PDF (1894KB)(243) Cited By (9)
Abstract:
Guideline Interpretation
Interpretation of Guidelines for diagnosis and treatment of primary liver cancer in China (2019edition)
Wang Shan, Wu QingWang, Li XiaoKe, Ye YongAn
2020, 36(5): 996-999. DOI: 10.3969/j.issn.1001-5256.2020.05.009
Abstract(1069) PDF (1851KB)(729) Cited By (79)
Abstract:

In June 2017, the National Health and Family Planning Commission of the People's Republic of China issued the Guidelines for diagnosis and treatment of primary liver cancer in China(2017 edition), which is of great significance as it provides recommendations on the diagnosis, staging, and treatment ...

Coronavirus disease 2019 and hepatobiliary & pancreatic diseases
Management strategies for patients with chronic viral hepatitis during the coronavirus disease 2019 epidemic
Li LiangLiang, Yu YanYan
2020, 36(5): 1000-1003. DOI: 10.3969/j.issn.1001-5256.2020.05.010
Abstract:

During the severe epidemic of coronavirus disease 2019(COVID-19) in China, some patients with chronic viral hepatitis have difficulties in attending the hospital and getting medical treatment. This article introduces the management strategies for patients with chronic viral hepatitis in medical inst...

Liver injury in coronavirus disease 2019
Lai ShuJie, Cui HongLi, Chen DongFeng, Kuang Yi
2020, 36(5): 1004-1007. DOI: 10.3969/j.issn.1001-5256.2020.05.011
Abstract(1060) PDF (1895KB)(162) Cited By (2)
Abstract:

At present, coronavirus disease 2019(COVID-19) caused by 2019 novel coronavirus(2019-nCoV) infection has spread rapidly in China and more than 70 countries around the world and thus become a public health event of international concern. In addition to fever and respiratory symptoms, varying degrees ...

Original articles_Viral hepatitis
Value of combined measurement of hepatitis B virus covalently closed circular DNA,HBsAg,and hepatitis B virus pregenomic RNA in predicting the treatment outcome of HBeAg-positive chronic hepatitis B patients treated with entecavir
Wang Ying, Zhao Kui, Qin JianZhong
2020, 36(5): 1008-1013. DOI: 10.3969/j.issn.1001-5256.2020.05.012
Abstract(1446) PDF (2112KB)(186) Cited By (21)
Abstract:

Objective To investigate value of combined measurement of serum hepatitis B virus(HBV) covalently closed circular DNA(cccDNA), HBsAg, and HBV pregenomic RNA(pgRNA) in predicting the treatment outcome of HBeAg-positive chronic hepatitis B(CHB) patients treated with entecavir(ETV).Methods A total of 8...

Association of genotype with cellular immunity and coagulation function in chronic hepatitis B virus infection patients with different disease spectrums in Sichuan,China
Li ShouJuan, Wang Li, Chen Zhu, Hu ChaoXia, Wang Lei, Wu Bei, Zhu Li, Duan Meng
2020, 36(5): 1014-1018. DOI: 10.3969/j.issn.1001-5256.2020.05.013
Abstract(1089) PDF (1912KB)(132) Cited By (5)
Abstract:

Objective To investigate the genotype distribution of chronic hepatitis B virus(HBV) infection patients with different disease spectrums in Sichuan, China, as well as the association of genotypes with cellular immunity and coagulation function.Methods A total of543 patients with chronic HBV infectio...

Effect of T-lymphocyte phenotype on immune status in chronic hepatitis B virus infection and its application value
Zhao JinHua, Li JunFeng, Mao XiaoRong
2020, 36(5): 1019-1023. DOI: 10.3969/j.issn.1001-5256.2020.05.014
Abstract:

Objective To investigate the association between T-lymphocyte phenotype and immune status in chronic hepatitis B(CHB)and its application value.Methods A total of 77 CHB patients who attended The First Hospital of Lanzhou University from January 2015 to May 2019 were enrolled, and according to the st...

microRNA-18a upregulates the regulatory immune function in patients with chronic hepatitis B through the PPARα/γ signaling pathway
Ye Jun, Han ShanShan, Lu XinYi, Shang YuTao, Feng ZhiQiang
2020, 36(5): 1024-1028. DOI: 10.3969/j.issn.1001-5256.2020.05.015
Abstract:

Objective To investigate the effect of microRNA-18 a(miRNA-18 a) on the regulatory immune function in patients withchronic hepatitis B(CHB) through the PPARα/γ signaling pathway.Methods A total of 98 CHB patients and 96 patients without hepatitisB, who were treated in Air Force Special Medical Cente...

Original articles_Liver fibrosis and liver cirrhosis
Value of globulin-platelet model in diagnosis of liver fibrosis in patients with chronic hepatitis B virus infection and alanine aminotransferase <2 ×upper limit of normal
Zhang JieLing, Zou GuiZhou, Gao YuFeng, Li JiaBin
2020, 36(5): 1029-1032. DOI: 10.3969/j.issn.1001-5256.2020.05.016
Abstract(1059) PDF (2056KB)(171) Cited By (3)
Abstract:

Objective To investigate the value of globulin-platelet(GP) model in the diagnosis of liver fibrosis in patients with chronic hepatitis B virus(HBV) infection and alanine aminotransferase(ALT)<2 ×upper limit of normal(ULN).Methods A retrospective analysis was performed for the clinical data of 65...

Influence of different virologic responses on the prognosis of patients with decompensated hepatitis B cirrhosis
Ji XiaoXiao, Li Li, Fu JuanJuan, Pan XiuCheng
2020, 36(5): 1033-1037. DOI: 10.3969/j.issn.1001-5256.2020.05.017
Abstract(916) PDF (2014KB)(138) Cited By (14)
Abstract:

Objective To investigate the influence of different virologic responses on long-term survival rate and incidence rate of liver cancer in patients with decompensated hepatitis B cirrhosis.Methods A total of 378 patients with decompensated hepatitis B cirrhosis who were admitted to The Affiliated Hosp...

Effect of hepatocyte transplantation in treatment of rats with liver cirrhosis and small-for-size syndrome
Jia Lei, Wen XinWei, Li HaiYang
2020, 36(5): 1038-1042. DOI: 10.3969/j.issn.1001-5256.2020.05.018
Abstract:

Objective To investigate the effect of hepatocyte transplantation(HCT) in the treatment of rats with liver cirrhosis and small-for-size syndrome(SFSS).Methods A total of 40 male Sprague-Dawley rats were given subcutaneous injection of carbon tetrachloride and oral administration of alcohol to establ...

Original articles_Liver neoplasms
Changes in intestinal flora in patients with primary liver cancer after transcatheter arterial chemoembolization
Li KeZhi, Wei JiaKang, Han ZhiWei, Chou WenXia, Chen XinXin, Huang Shan, He JianBo, Wu GuoBin, Chen Chuang
2020, 36(5): 1043-1049. DOI: 10.3969/j.issn.1001-5256.2020.05.019
Abstract(1168) PDF (3135KB)(155) Cited By (23)
Abstract:

Objective To investigate the changes in the diversity and structure of intestinal flora in patients with primary liver cancer after transcatheter arterial chemoembolization(TACE).Methods A total of 65 patients with primary liver cancer(among whom 20 received TACE) who were treated in The Affiliated ...

Expression and clinical significance of CCDC34 in hepatocellular carcinoma:An analysis based on The Cancer Genome Atlas database
Xiang XiaoHui, Mao Jun, Li Hai
2020, 36(5): 1050-1054. DOI: 10.3969/j.issn.1001-5256.2020.05.020
Abstract(1272) PDF (2224KB)(163) Cited By (2)
Abstract:

Objective To investigate the expression and clinical value of coiled-coil domain-containing protein 34(CCDC34) in hepatocellular carcinoma(HCC), and to predict the role of CCDC34 in the development and progression of HCC.Methods The datasets of HCC were downloaded from The Cancer Genome Atlas(TCGA) ...

Original articles_Other liver diseases
Efficacy and safety of regional citrate anticoagulation in patients with severe liver diseases and acute kidney injury receiving continuals renal replacement therapy
Ning QiQi, Gao Yuan, Duan MeiLi, Liu HaiXia, Meng QingHua, Yu HongWei, Hu ZhongJie, Zhu YueKe
2020, 36(5): 1055-1058. DOI: 10.3969/j.issn.1001-5256.2020.05.021
Abstract(1198) PDF (1970KB)(136) Cited By (21)
Abstract:

Objective To investigate the efficacy and safety of regional citrate anticoagulation(RCA) in patients with severe liver diseasesand acute kidney injury(AKI) receiving continuous renal replacement therapy(CRRT).Methods A retrospective analysis was performedfor the medical records and first-time CRRT ...

Clinical and biochemical features of bile duct injury type of drug-induced liver injury
Ye LiHong, Wang ChongKui, Shao Chen, Zhang HaiCong, Liu ZhiQuan, Wang TaiLing
2020, 36(5): 1059-1064. DOI: 10.3969/j.issn.1001-5256.2020.05.022
Abstract(1063) PDF (2219KB)(160) Cited By (5)
Abstract:

Objective To investigate the pathological and biochemical features of each pathological subtype of bile duct injury type of drug-induced liver injury(DILI), and to verify the value and significance of pathological classification of DILI.Methods A retrospective analysis was performed for the clinical...

Clinical features of patients with sepsis-induced cholestatic jaundice and risk factors for death
Lei Yu, Li JiaJia, Liu RongAn, Ceng Fan, Li GuiSen, Lan YunPing
2020, 36(5): 1065-1071. DOI: 10.3969/j.issn.1001-5256.2020.05.023
Abstract(1199) PDF (1932KB)(190) Cited By (8)
Abstract:

Objective To investigate the clinical features of patients with sepsis-induced cholestatic jaundice and the risk factors for death.Methods A retrospective analysis was performed for the clinical data of 139 patients with sepsis-induced cholestatic jaundice who were admitted to Surgical Intensive Car...

Virulence gene detection and homology analysis of Klebsiella pneumoniae inducing liver abscess
Xi JianFeng, Xu Yi, Guo YuHang, Li HuiLing, Wang Yong
2020, 36(5): 1072-1076. DOI: 10.3969/j.issn.1001-5256.2020.05.024
Abstract:

Objective To investigate the serotype and virulence genes of Klebsiella pneumoniae capsule for in-hospital liver abscess, as well as the homology of these strains.Methods A total of 26 non-repetitive strains of Klebsiella pneumoniae isolated from the patients with liver abscess in The First Affiliat...

Effect of apigenin on H2O2-induced oxidative injury in human hepatocytes L02
Du YiChao, Zhang Hao, Huang ZhiWei, Pu ShiLin, Qian BaoLin, Lai Li, Tan Peng, Xia XianMing, Fu WenGuang
2020, 36(5): 1077-1081. DOI: 10.3969/j.issn.1001-5256.2020.05.025
Abstract(1143) PDF (2245KB)(159) Cited By (9)
Abstract:

Objective To investigate the protective effect of apigenin against H2O2-induced injury in human hepatocytes(L02).Methods L02 cells were treated with H2O2 to establish a model of oxidative injury. CCK-8 assay was used to measure cell viability; DCFH-DA was used to measure the production of reactive o...

Original articles_Biliary diseases
Influencing factors for stent obstruction after endoscopic retrograde biliary drainage in patients with refractory common bile duct stones
Tian Wen, Zhou ZhongYin
2020, 36(5): 1082-1086. DOI: 10.3969/j.issn.1001-5256.2020.05.026
Abstract(1055) PDF (2017KB)(138) Cited By (14)
Abstract:

Objective To investigate the influencing factors for stent obstruction after endoscopic retrograde biliary drainage(ERBD) forrefractory common bile duct stones.Methods A total of 126 patients who underwent ERBD for refractory common bile duct stones inRenmin Hospital of Wuhan University from January...

Expression of intergenic long non-coding RNA RP11-488L18.10 in cholangiocarcinoma and its association with prognosis
Tan ZhengRong, Feng DaLi, Zhang Qing
2020, 36(5): 1087-1090. DOI: 10.3969/j.issn.1001-5256.2020.05.027
Abstract:

Objective To screen out the key intergenic long non-coding RNAs(lncRNAs) in cholangiocarcinoma(CCA) and their association with patient prognosis.Methods CCA expression and clinical data were obtained from The Cancer Genome Atlas(TCGA). High-throughput gene expression data in GSE107943 dataset were o...

Original articles_Pancreatic diseases
Clinical features and prognosis of acute pancreatitis with nonalcoholic fatty liver disease
Yan YongFeng, Jiang Xin, Zhong Rui, Xu Huan, Peng Yan, Tang XiaoWei
2020, 36(5): 1091-1096. DOI: 10.3969/j.issn.1001-5256.2020.05.028
Abstract(1444) PDF (1938KB)(136) Cited By (9)
Abstract:

Objective To investigate the association of nonalcoholic fatty liver disease( NAFLD) with the severity of acute pancreatitis(AP).Methods A total of 398 patients with AP who were admitted to The Affiliated Hospital of Southwest Medical University from January to August 2019 were enrolled, among whom ...

Clinical effect of epidermal growth factor receptor-targeted agents in treatment of advanced pancreatic cancer:A Meta-analysis
Zhou ZiDong, Li RenLi, Chen Kai, Zhang WenCheng, Xia ShiHai
2020, 36(5): 1097-1103. DOI: 10.3969/j.issn.1001-5256.2020.05.029
Abstract(1257) PDF (2685KB)(145) Cited By (2)
Abstract:

Objective To systematically evaluate the clinical effect of epidermal growth factor receptor( EGFR)-targeted agents in the treatment of advanced pancreatic cancer.Methods EMbase, PubMed, Cochrane Library, Clinical Trials, CNKI, Wanfang Data, and VIP were searched for randomized controlled trials(RCT...

Pathological typing and clinical features of Vater ampullary adenocarcinoma
Feng YongHeng, Zheng ZeQun, Liu ShuangYue, Zhao YouCai, Yang KunXing, Xi PengCheng
2020, 36(5): 1104-1108. DOI: 10.3969/j.issn.1001-5256.2020.05.030
Abstract(1642) PDF (2372KB)(202) Cited By (8)
Abstract:

Objective To investigate the features and clinical data of different pathological types of Vater ampullary adenocarcinoma and the influencing factors for prognosis, and to improve the prognostic evaluation and treatment outcome of Vater ampullary adenocarcinoma after surgery.Methods A retrospective ...

Brief reports
Clinical characteristics of primary biliary cholangitis in Kazakhs, Xinjiang, China: An analysis of 65 cases
Zhao FengCong, Liu Lan, Zhang YongPing, Ma AnLin
2020, 36(5): 1109-1111. DOI: 10.3969/j.issn.1001-5256.2020.05.031
Abstract:
Experience in treatment of pancreatic body/tail tumor using distal pancreatectomy with celiac axis resection
Du Yan, Wang XiaoDong, Xin ZeChang, Mao FeiYu, Qian XiaoWei, Li DuGuang, Yao Jie
2020, 36(5): 1112-1114. DOI: 10.3969/j.issn.1001-5256.2020.05.032
Abstract:
Case reports
Hepatic dysplastic nodules with Budd-Chiari syndrome misdiagnosed as hepatocellular carcinoma: A case report
Pang RunHua, Zhu YaQing
2020, 36(5): 1115-1116. DOI: 10.3969/j.issn.1001-5256.2020.05.033
Abstract:
A case of Wilson’s disease with central diabetes insipidus as the initial manifestation
Zhao Mao, Liu Rui, Hu Xiao
2020, 36(5): 1117-1119. DOI: 10.3969/j.issn.1001-5256.2020.05.034
Abstract(1015) PDF (1960KB)(147) Cited By (2)
Abstract:
A male case of primary biliary cholangitis with anti-leucine-rich glioma-inactivated 1 antibody-associated encephalitis: A case report 
Liu Man, Tang TongDan, Liu YongHua, Zhu Lei
2020, 36(5): 1120-1121. DOI: 10.3969/j.issn.1001-5256.2020.05.035
Abstract:
A case of cat scratch disease of the liver with acute cholangitis as the initial symptom
Li HeYu, Gao XiaoPing, Wang Ju
2020, 36(5): 1122-1124. DOI: 10.3969/j.issn.1001-5256.2020.05.036
Abstract:
A case of liver abscess caused by fish bone
Yang Yan, Wei MingYong, Deng JieWen, Tang WeiDong
2020, 36(5): 1125-1126. DOI: 10.3969/j.issn.1001-5256.2020.05.037
Abstract:
Myelosuppression induced by human parvovirus B19 infection after liver transplantation: A case report
Gao LuHua, Peng MeiJuan, Nie QingHe, Wang YuanYuan
2020, 36(5): 1127-1128. DOI: 10.3969/j.issn.1001-5256.2020.05.038
Abstract:
IgG4-related biliary and pancreatic diseases with significantly elevated CA19-9: A case report
Yu LeLe, Xiong Fang, Lu Jun
2020, 36(5): 1129-1130. DOI: 10.3969/j.issn.1001-5256.2020.05.039
Abstract:
A case of splenectopia in the liver
Chen JiaCheng, Chen XiaoJing, Zhuang ChunYu, Liu FuJin, Luo ShiShi, Chen Liang, Wu JinCai, Zhou KaiLun
2020, 36(5): 1131-1133. DOI: 10.3969/j.issn.1001-5256.2020.05.040
Abstract:
Reviews
Current status of the diagnosis and treatment of chronic hepatitis B virus infection with immune control
Zhou LuLu, Liu Na, Li ChunXia, Dong Bing, Zhang Nan, Ren DanDan, Xu GuangHua
2020, 36(5): 1134-1137. DOI: 10.3969/j.issn.1001-5256.2020.05.041
Abstract(1172) PDF (1905KB)(194) Cited By (6)
Abstract:

Patients with chronic hepatitis B virus(HBV) infection with immune control generally have no or little liver damage, with a low incidence rate of adverse events, and spontaneous HBsAg seroclearance may occur in some patients. Most scholars do not recommend antiviral therapy for such patients in Chin...

Role of pyroptosis in the pathogenesis of hepatic fibrosis
Fan Chang, Wu FuRong, Zhang JiaFu, Jiang Hui
2020, 36(5): 1138-1140. DOI: 10.3969/j.issn.1001-5256.2020.05.042
Abstract(1140) PDF (1892KB)(164) Cited By (8)
Abstract:

Hepatic fibrosis is a reversible pathological reaction of the liver during the self-repair of various chronic liver injuries and can progress to liver cirrhosis and liver cancer. Pyroptosis is a new type of programmed cell death different from apoptosis and necrosis and is closely associated with th...

Cell signaling pathways associated with liver fibrosis and potential therapeutic strategies
Deng YangYang, Ge ShanFei, Yu YanQing, Xiong Ying
2020, 36(5): 1141-1145. DOI: 10.3969/j.issn.1001-5256.2020.05.043
Abstract(1974) PDF (1915KB)(312) Cited By (24)
Abstract:

Liver fibrosis is a chronic liver injury caused by various etiologies and a complex pathological change with the activation of hepatic stellate cells as the central link, and various signaling pathways are involved in the regulation of such complex lesions. It has the dual nature of repair and damag...

Mechanism of action of homocysteine in the development of liver fibrosis and liver cirrhosis
Wang YaGang, Hu GuoXin
2020, 36(5): 1146-1149. DOI: 10.3969/j.issn.1001-5256.2020.05.044
Abstract(1143) PDF (1936KB)(144) Cited By (10)
Abstract:

Homocysteine(Hcy) has attracted more and more attention in the medical field since it was found to be closely associated with cardiovascular and cerebrovascular diseases, hypertension, diabetes, kidney diseases, skeletal system diseases, and even mental illnesses.In recent years, the application of ...

Association between cytochrome P450 gene polymorphism and drug-induced liver injury
Wang QiaoLing, Zou ZhengSheng
2020, 36(5): 1150-1153. DOI: 10.3969/j.issn.1001-5256.2020.05.045
Abstract(1151) PDF (1913KB)(185) Cited By (13)
Abstract:

As the prevalence rate of drug-induced liver injury increases year by year, the pathogenesis of drug-induced liver injury has become the focus of attention. As a large family, CYP450 enzymes participate in almost all oxidative metabolic reactions of drugs in the human liver. Recent studies have show...

Research advances in nonalcoholic fatty liver disease in lean individuals
A RuHan, Jia HaiYan, Ding YanHua, Niu JunQi
2020, 36(5): 1154-1159. DOI: 10.3969/j.issn.1001-5256.2020.05.046
Abstract:

The incidence rate of nonalcoholic fatty liver disease(NAFLD) is continuously increasing in the world, and NAFLD is a major cause of chronic liver disease in developed countries such as the United States and may become the most common chronic liver disease in China in the future. NAFLD is often obse...

Mechanism of action of intestinal farnesoid X receptor in nonalcoholic fatty liver disease and related targeted drugs
Zhang KaiLing, Li LiangPing
2020, 36(5): 1160-1163. DOI: 10.3969/j.issn.1001-5256.2020.05.047
Abstract:

The incidence rate of nonalcoholic fatty liver disease(NAFLD) is gradually increasing in recent years, and the treatment of NAFLD is unsatisfactory due to the failure in lifestyle adjustment and a lack of effective drugs. Farnesoid X receptor(FXR), as the main bile acid receptor, may affect NAFLD by...

Diagnostic and prognostic value of autoantibodies in primary biliary cholangitis
Dang FuTao, Tang YingMei
2020, 36(5): 1164-1166. DOI: 10.3969/j.issn.1001-5256.2020.05.048
Abstract:

Primary biliary cholangitis(PBC) is an autoimmune cholestatic liver disease with unknown etiology. Liver biopsy is an important diagnostic tool, but its clinical application is limited due to its invasiveness. Autoantibodies have special diagnostic and prognostic value for PBC, especially anti-mitoc...

Role of nuclear receptor in the development and progression of primary biliary cholangitis
Yu HaiYan, Tang YingMei
2020, 36(5): 1167-1170. DOI: 10.3969/j.issn.1001-5256.2020.05.049
Abstract:

Primary biliary cholangitis(PBC) is an chronic progressive intrahepatic cholestasis autoimmune liver disease with unknown causes, and at present, the etiology and pathogenesis of PBC remain unclear. Nuclear receptor is a ligand-dependent transcription factor superfamily that regulates cell growth an...

Role of the Hippo signaling pathway in the development and progression of primary liver cancer
Hong YingHui, Wang Chun, Ye MingLiang, Luo Jie, Liu JiaLiang, Ren Chao, Lan SiYu, Zhao Qiu, Chang Ying
2020, 36(5): 1171-1174. DOI: 10.3969/j.issn.1001-5256.2020.05.050
Abstract:

The incidence rate of primary liver cancer continues to increase around the world, with a younger age of onset and poorer prognosis. As the most classic regulator of cell polarity and density, mechanical signal transduction, cell proliferation, and organ development, the Hippo pathway can promote th...

Mechanism and clinical effect of regorafenib in treatment of hepatocellular carcinoma
Lu: XiaoWen, Wang Su
2020, 36(5): 1175-1180. DOI: 10.3969/j.issn.1001-5256.2020.05.051
Abstract(1467) PDF (2091KB)(160) Cited By (9)
Abstract:

As the first-line drug for the treatment of primary liver cancer, sorafenib has been widely used in clinical practice, but its drug resistance and toxic and side effects have become increasingly apparent, along with limited efficacy. In recent years, the research on regorafenib for the treatment of ...

Microvascular invasion in hepatocellular carcinoma:Definition and criteria for pathological grading
He XuChang, An WenHui, Zhao HaiQuan, Shen Hui, Yang Jing, Mo XiaoHua
2020, 36(5): 1181-1184. DOI: 10.3969/j.issn.1001-5256.2020.05.052
Abstract(2891) PDF (1896KB)(298) Cited By (15)
Abstract:

The prognosis of hepatocellular carcinoma(HCC) is closely associated microvascular invasion(MVI), and in recent years, more and more clinical studies have been conducted on MVI, but there are few articles on the development of basic pathology and related controversies. As the basis of clinical resea...

Research advances in microvascular invasion in hepatocellular carcinoma
He Tao, Jiang Yu, Li Qiu, Fu WenGuang
2020, 36(5): 1185-1189. DOI: 10.3969/j.issn.1001-5256.2020.05.053
Abstract(1212) PDF (1928KB)(142) Cited By (2)
Abstract:

Although hepatocellular carcinoma(HCC) is treated with a combination of multiple disciplines and methods, there are still a large number of patients with poor prognosis. Current studies have shown that microvascular invasion(MVI) is one of the important factors for poor prognosis of HCC, but MVI can...

Current status of the research on laparoscopic cholecystectomy
Xie WenQiang, Deng HongYang, Wei FengXian, Du Jian, Shao ZiWei, Xu XiaoDong, Zhang YouCheng
2020, 36(5): 1190-1192. DOI: 10.3969/j.issn.1001-5256.2020.05.054
Abstract(1820) PDF (1884KB)(241) Cited By (73)
Abstract:

Laparoscopic cholecystectomy is considered the gold standard for the treatment of symptomatic cholecystolithiasis and has become one of the typical representatives of minimally invasive surgery. This article briefly introduces the contraindication and indication for laparoscopic cholecystectomy, com...